This transcript is automatically generated
Now let's get back of this -- Eli Lilly alzheimer's drug let's get a professional medical opinion on that new -- bringing in plays doctor Marc Siegel of the sickle.
Let me can I just horror -- we'll give you -- in understanding of this story so far this developing and is very technical.
Seems like there's a new class of drugs being tested.
And time amyloid I think -- got that right.
They may be able to block the formation of plaque in human brains that clogs up memory.
May be able to arrest the progress of alzheimer's about it right.
Almost had to let me we'll look back through little place in alzheimer's disease there's something called beta amyloid which you referred to a -- it comes up the works in the brain.
A study in Iceland recently showed that.
A population that didn't make that protein as much.
Had seven times less chance of developing -- -- I consider that study the holy Grail because now.
Instead of thinking that beta amyloid just sitting there we now think it's actually the cause of -- -- that's a big deal until along comes something we called targeted therapies Stewart and this one stolen the stolen as a mob is the name of it.
It targets the amyloid it's literally like sending a guided missile into the amyloid and exploding -- -- mine on the imagine that the earlier in the game you do that.
The better off if you walk in -- it's had an extraordinary effect now we're starting the studies in humans -- -- -- -- is reporting now.
-- in mild to moderate alzheimer's it's having -- a strong effect.
I think as a preventative.
You before you even develop it's going to be an enormous home run with five million people having alzheimer's and families everybody worried about it.
With the technology to find out times before it actually occurs if you use this drug earlier in the game -- might really be about Citi.
I wanna recap this because that's the really big positive in in my -- always a total outside.
Before you show any symptoms of memory loss and -- on way before then.
If you start using this drug.
There's a possibility that he premiums the arrival of -- -- -- it is preventive medicine don't weigh in advance.
That would make it a Blockbuster -- new line there.
Better believe because I have to add to that one little bit of science here analyzed.
Have now progressed to the point.
What we can pick it up before it occurs clinically before it gets you sent before you see.
Any memory loss we can start to pick it up on an MRI and so they've they have it.
It's coming down the -- you know you're gonna develop -- in five years you hit with a preventive drug like this they're targets that amyloid and -- prevent the disease from actually developing very exciting stuff.
I'm gonna make a prediction people like myself.
-- middle age if you wanna Coleman that.
I forget names I'm a little forgetful on I'm being serious now I can see the day when I would come into your office -- -- doctor.
I'm beginning to pick up a few names -- how about -- Lilly drug please and.
How I don't know how other than what MRI I don't wanna point out by the way from a business point of that Pfizer and J&J are also working on similar drugs that haven't had the same results -- in clinical trials.
-- was referring to that but there's other companies of all besides -- on the.
And -- I'm are -- is the anti amyloid treatment system.
-- -- -- -- Anti amyloid and it's called the monoclonal.
Antibody it's an antibody that you do that you -- -- and targets that -- got it.
Doctor that was valuable stuff I think that's very exciting news amenities -- our audience today doctor Marc Siegel we thank you very much thanks or.